A Perry1, C S Graffeo1, G Kleinstern2, L P Carlstrom1, M J Link1,3, A A Rabinstein4. 1. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA. 2. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 3. Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN, USA. 4. Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. Rabinstein.Alejandro@Mayo.edu.
Abstract
BACKGROUND: Acute hydrocephalus is a common complication of aneurysmal subarachnoid hemorrhage (aSAH); however, attempts to predict shunt-dependent chronic hydrocephalus using clinical parameters have been equivocal. METHODS: Cohort study of aSAH is treated with external ventricular drainage (EVD) placement at our institution, 2001-2016, via logistic regression. EVD-related parameters included mean/total EVD output (days 0-2), EVD days, EVD days ≤ 5 mmHg, and wean/clamp fails. aSAH outcomes assessed included ventriculoperitoneal shunt (VPS) placement, delayed cerebral ischemia (DCI), radiographic infarction (RI), symptomatic vasospasm (SV), age, and aSAH grades. RESULTS: Two hundred and ten aSAH patients underwent EVD treatment for a median 12 days (range 1-54); 85 required VPS (40%). On univariate analysis, EVD output, total EVD days, EVD days ≤ 5 mmHg, and wean/clamp trial failures were significantly associated with VPS placement (p < 0.01 for all parameters). No EVD output parameter demonstrated a significant association with DCI, RI, or SV. On multivariate analysis, EVD output was a significant predictor of VPS placement, after adjusting for age and clinical and radiological grades; the optimal threshold for predicting VPS placement was mean daily output > 204 ml on days 0-2 (OR 2.59, 95% CI 1.31-5.07). Multiple wean failures were associated with unfavorable functional outcome, after adjusting for age, grade, and VPS placement (OR 1.65, 95% CI 1.10-2.47). We developed a score incorporating age, grade and EVD parameters (MAGE) for predicting VPS placement after aSAH. CONCLUSIONS: EVD output parameters and wean/clamp trial failures predicted shunt dependence in an age- and grade-adjusted multivariable model. Early VPS placement may be warranted in patients with MAGE score ≥ 4, particularly following 2 failed wean trials.
BACKGROUND: Acute hydrocephalus is a common complication of aneurysmal subarachnoid hemorrhage (aSAH); however, attempts to predict shunt-dependent chronic hydrocephalus using clinical parameters have been equivocal. METHODS: Cohort study of aSAH is treated with external ventricular drainage (EVD) placement at our institution, 2001-2016, via logistic regression. EVD-related parameters included mean/total EVD output (days 0-2), EVD days, EVD days ≤ 5 mmHg, and wean/clamp fails. aSAH outcomes assessed included ventriculoperitoneal shunt (VPS) placement, delayed cerebral ischemia (DCI), radiographic infarction (RI), symptomatic vasospasm (SV), age, and aSAH grades. RESULTS: Two hundred and ten aSAHpatients underwent EVD treatment for a median 12 days (range 1-54); 85 required VPS (40%). On univariate analysis, EVD output, total EVD days, EVD days ≤ 5 mmHg, and wean/clamp trial failures were significantly associated with VPS placement (p < 0.01 for all parameters). No EVD output parameter demonstrated a significant association with DCI, RI, or SV. On multivariate analysis, EVD output was a significant predictor of VPS placement, after adjusting for age and clinical and radiological grades; the optimal threshold for predicting VPS placement was mean daily output > 204 ml on days 0-2 (OR 2.59, 95% CI 1.31-5.07). Multiple wean failures were associated with unfavorable functional outcome, after adjusting for age, grade, and VPS placement (OR 1.65, 95% CI 1.10-2.47). We developed a score incorporating age, grade and EVD parameters (MAGE) for predicting VPS placement after aSAH. CONCLUSIONS:EVD output parameters and wean/clamp trial failures predicted shunt dependence in an age- and grade-adjusted multivariable model. Early VPS placement may be warranted in patients with MAGE score ≥ 4, particularly following 2 failed wean trials.
Authors: Georgios A Maragkos; Alejandro Enriquez-Marulanda; Mohamed M Salem; Luis C Ascanio; Kohei Chida; Raghav Gupta; Abdulrahman Y Alturki; Kimberly P Kicielinski; Christopher S Ogilvy; Justin M Moore; Ajith J Thomas Journal: World Neurosurg Date: 2018-09-27 Impact factor: 2.104
Authors: Luis C Ascanio; Raghav Gupta; Nimer Adeeb; Justin M Moore; Christoph J Griessenauer; Julie Mayeku; Yaw Tachie-Baffour; Ranjit Thomas; Abdulrahman Y Alturki; Philip G R Schmalz; Christopher S Ogilvy; Ajith J Thomas Journal: J Neurosurg Date: 2018-03-16 Impact factor: 5.115
Authors: David Y Chung; Bradford B Thompson; Monisha A Kumar; Ali Mahta; Shyam S Rao; James H Lai; Aleksey Tadevosyan; Kathryn Kessler; Joseph J Locascio; Aman B Patel; Wazim Mohamed; DaiWai M Olson; Sayona John; Guy A Rordorf Journal: Neurocrit Care Date: 2021-09-08 Impact factor: 3.532